FDA committee rejects two IQOS MRTP claims, approves one
25th January 2018 - News analysis |
Agency’s science committee agrees that PMI product decreases exposure to dangerous chemicals, but won’t accept broader claims of long-term risk reduction
Agency’s science committee agrees that PMI product decreases exposure to dangerous chemicals, but won’t accept broader claims of long-term risk reduction
PMI has responded forcefully after a Swiss research team claimed its iQOS heat-not-burn system released “the same harmful constituents of conventional cigarette smoke”
The launch of PMI’s heated tobacco device iQOS in South Africa has had a positive reaction even from potential competitors, who hope it will increase general awareness of alternatives to combustible cigarettes.
Philip Morris International (PMI) has submitted its iQOS heat-not-burn system for approval by the U.S. Food and Drug Administration (FDA).
Get 7 days of FREE platform access: Demo our data contents without commitment
"*" indicates required fields